The store will not work correctly when cookies are disabled.
7,7-Dimethyl-1-(pyridin-2-ylmethyl)-6,7-dihydro-1H,5H-pyrido[1,2,3-de]quinoxaline-2,3-dione
ID: ALA5208145
PubChem CID: 168295737
Max Phase: Preclinical
Molecular Formula: C19H19N3O2
Molecular Weight: 321.38
Associated Items:
Names and Identifiers
Canonical SMILES: CC1(C)CCn2c(=O)c(=O)n(Cc3ccccn3)c3cccc1c32
Standard InChI: InChI=1S/C19H19N3O2/c1-19(2)9-11-21-16-14(19)7-5-8-15(16)22(18(24)17(21)23)12-13-6-3-4-10-20-13/h3-8,10H,9,11-12H2,1-2H3
Standard InChI Key: HSTORFHDBYJYGQ-UHFFFAOYSA-N
Molfile:
RDKit 2D
24 27 0 0 0 0 0 0 0 0999 V2000
-0.3572 0.9756 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0718 1.3879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7864 0.9756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7864 0.1511 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.0718 -0.2611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0718 -1.0855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3572 -1.4978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3572 -1.0855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3572 -0.2611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3572 0.1511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7864 -1.4978 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5009 -1.0855 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5009 -0.2611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3741 -2.2124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1986 -2.2124 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.5009 1.3879 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.0718 2.2124 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
0.3572 1.3879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0718 0.9756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7864 1.3879 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5009 0.9756 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5009 0.1511 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7864 -0.2611 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0718 0.1511 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
1 2 1 0
2 3 1 0
3 4 1 0
4 5 1 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 10 1 0
1 10 1 0
5 10 2 0
6 11 1 0
11 12 1 0
12 13 1 0
4 13 1 0
11 14 1 0
11 15 1 0
3 16 2 0
2 17 2 0
1 18 1 0
18 19 1 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
19 24 2 0
M END
Associated Targets(non-human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 321.38 | Molecular Weight (Monoisotopic): 321.1477 | AlogP: 2.29 | #Rotatable Bonds: 2 |
Polar Surface Area: 56.89 | Molecular Species: NEUTRAL | HBA: 5 | HBD: ┄ |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): ┄ | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.12 | CX LogP: 2.02 | CX LogD: 2.02 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.68 | Np Likeness Score: -0.81 |
References
1. Shingare RD, MacMillan JB, Reddy DS.. (2022) Antibiotic natural product hunanamycin A: Lead identification towards anti-Salmonella agents., 236 [PMID:35421661] [10.1016/j.ejmech.2022.114245] |